Jade Forwood

Professor Jade Forwood is a distinguished academic at Charles Sturt University, holding positions as Program Lead for Biosecurity at the Gulbali Institute and Director of THRIIVE. He earned his BBiomed Sci (Hons 1) and PhD from the Australian National University. His research focuses on antiviral strategies, vaccine development, and nucleocytoplasmic transport mechanisms, with significant contributions to biosecurity and medical research. He has secured over $40 million in grants, including NHMRC, NIH, and ARC awards. Notable achievements include advancements in treatments for metastatic breast cancer and vaccines for Psittacine Beak and Feather Disease. His lab employs structural biology techniques, including synchrotron-based studies, to understand viral-host interactions.

Education: PhD in Biochemistry (ANU), BBiomed Sci (Hons 1). Research highlights include collaborations with Duke-NUS and Monash University on flavivirus antivirals and cancer therapies. Awards include the Frank Fenner Medal and FAOBMB Young Scientist Award. THRIIVE, directed by Prof. Forwood, coordinates 32 industry and government partners in virology and epidemiology training. His lab addresses critical threats such as Hendra, Nipah, and Dengue viruses.

Scientific Awards: Frank Fenner Medal, NHMRC CJ Martin Fellowship, ARC Future Fellowship, FAOBMB Young Scientist Award, University Medal, and multiple Vice-Chancellor awards for research and supervision excellence.

Grants and Advising: 30+ grants totaling >$40M; 18 supervised students (specific names not listed). Lab projects include vaccine development for endangered parrots and dual enzyme inhibitors for antibiotic resistance.

Labs/Teams: The Forwood Lab at the National Life Sciences Hub (NaLSH) focuses on viral nuclear trafficking and immune evasion. Collaborations span structural biology and clinical trials with Epiaxis Therapeutics.